The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Overview on pharmacoeconomics of basal insulin
Author(s): 
Pages: 46-51
Year: Issue:  15
Journal: Drug Evaluation

Abstract:  国际糖尿病联盟(IDF)的数据显示,2010年中国糖尿病患病率已达4.5%.仅次于印度[1].中华医学会糖尿病学分会在中国14个省市进行的糖尿病和代谢综合征患病率调查结果显示,在20岁以上的人口中,糖尿病的年龄标化患病率为9.7%,而糖尿病前期的年龄标化患病率更达到15.5%[2].
Related Articles
loading...